Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382627 · ClinicalTrials.gov registry record
Choroidal Thickness in Optic Neuropathy
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02382627 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 2 participants.
The verdict
NCT02382627 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study plans to learn more about the thickness of the choroid in patients with optic neuropathy. The choroid is a layer of blood vessels that supplies oxygen and nourishment to the outer layers of the retina. Patients are being asked to be in this research study because they have optic neuropathy and are receiving care at the University of Colorado Hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02382627
The ClinicalTrials.gov registry entry for NCT02382627 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02382627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02382627 about?
NCT02382627 is a clinical study titled "Choroidal Thickness in Optic Neuropathy". This study plans to learn more about the thickness of the choroid in patients with optic neuropathy. The choroid is a layer of blood vessels that supplies oxygen and nourishment to the outer layers of the retina. Patients are being asked to be in this research study because they have optic neuropath...
What is the current status of trial NCT02382627?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2015-03. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT02382627?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.